ReviewCureus2026
From the Field to the Emergency Room: A Systematic Case-Level Review of Exertional Rhabdomyolysis and Acute Kidney Injury in Athletes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exertional rhabdomyolysis is a potentially life-threatening syndrome caused by skeletal muscle breakdown with release of myoglobin and creatine kinase (CK) into the circulation. Clinical severity ranges from transient enzyme elevation to severe acute kidney injury (AKI) requiring renal replacement therapy (RRT). Although increasingly recognized, the published literature remains fragmented and largely descriptive. This review systematically aggregated case-level data to characterize biochemical severity and renal outcomes across different athlete populations and exertional contexts. PubMed, Embase, Scopus, and Google Scholar were searched through December 2025 for published cases of exertional rhabdomyolysis with reported renal outcomes. Case-level data were extracted for demographics, athlete type, CK and creatinine values, author-defined AKI, RRT requirement, myoglobinuria, and recovery status. 46 articles met inclusion criteria, contributing 65 patients. Most patients were male (n=59, 90.8%), with a median age of 24 years (interquartile range (IQR) 20-30). The median peak CK was 55,000 U/L (IQR 25,000-120,000). AKI occurred in 49 patients (75.4%), and RRT was required in 14 patients (21.5%). Myoglobinuria was documented in 58 patients (89.2%). Recreational athletes represented the largest subgroup (n=20, 30.8%), followed by students or school athletes (n=14, 21.5%), military or law-enforcement personnel (n=12, 18.5%), collegiate athletes (n=7, 10.8%), manual laborers or occupationally active individuals (n=6, 9.2%), professional athletes (n=3, 4.6%), and other or unknown exertional contexts (n=3, 4.6%). No deaths were reported, and complete renal recovery was documented in 62 patients (95.4%). Exertional rhabdomyolysis predominantly affects young, otherwise healthy men after unaccustomed or strenuous physical activity. Although AKI was common among published cases, survival and renal recovery were generally favorable. Standardized reporting of disease severity, AKI definitions, treatment strategies, and long-term renal outcomes is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.